Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2022. Go to the latest filing (Q3 2026)

22.6B USDQ3 2022
Total value of stock positions
22.6B USD
Positions
961
Share of the ten largest
11.9%

The ten largest positions Q3 2022

  1. Biogen 2.0%▲ +268.1%
  2. T-Mobile US 1.4%▼ −20.0%
  3. Alibaba Group (ADR) 1.2%▲ +489.7%
  4. AstraZeneca 1.2%▲ +144.0%
  5. Meta Platforms 1.2%▲ +89.3%
  6. Fidelity National Information Services 1.1%▲ +67.8%
  7. Palo Alto Networks 1.0%▲ +112.1%
  8. Arista Networks 1.0%▲ +4.6%
  9. Microsoft 1.0%▲ +148.0%
  10. Amazon 0.9%▲ +40.0%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q3 2022

Positions Q3 2022 per 13F filing, 50 of 297
Symbol Weight Shares Reported value Change Held since
Bunge Limited 0.2% 556,300 45.9M USD +563.1% increased Q2 2014 or earlier 34 quarters
Xenon Pharmaceuticals Inc 0.3% 1,640,072 59.2M USD +81.9% increased Q1 2015 31 quarters
AMZN Amazon 0.9% 1,837,862 207.7M USD +40.0% increased Q1 2017 23 quarters
PANW Palo Alto Networks 1.0% 1,413,942 231.6M USD +112.1% increasedafter 3:1 stock split Q1 2018 19 quarters
Sanofi 0.3% 1,727,777 65.7M USD +446.8% increased Q1 2018 19 quarters
LVS Las Vegas Sands 0.4% 2,199,307 82.5M USD +47.2% increased Q3 2018 17 quarters
American Finl Group Inc Ohio 0.3% 633,459 77.9M USD +84.3% increased Q4 2018 16 quarters
FIS Fidelity National Information Services 1.1% 3,331,045 251.7M USD +67.8% increased Q1 2019 15 quarters
Select Sector SPDR TR 0.7% 2,108,000 151.8M USD +51.7% increased Q1 2019 15 quarters
Childrens Pl Inc New < 0.1% 209,323 6.5M USD +363.1% increased Q1 2019 15 quarters
JBL Jabil 0.5% 2,063,000 119.1M USD +4.1% increased Q2 2019 14 quarters
Cytokinetics Inc < 0.1% 32,000 1.6M USD +63.0% increased Q2 2019 14 quarters
TRGP Targa Resources 0.1% 515,900 31.1M USD +79.5% increased Q3 2019 13 quarters
Neoleukin Therapeutics Inc < 0.1% 2,064,222 1.3M USD +43.6% increased Q4 2019 12 quarters
AZN AstraZeneca 1.2% 4,811,660 263.9M USD +144.0% increased Q1 2020 11 quarters
MSFT Microsoft 1.0% 957,370 223.0M USD +148.0% increased Q1 2020 11 quarters
DHR Danaher Corporation 0.3% 285,623 73.8M USD +113.1% increased Q1 2020 11 quarters
Exelixis Inc < 0.1% 923,700 14.5M USD +80.2% increased Q1 2020 11 quarters
META Meta Platforms 1.2% 1,932,078 262.1M USD +89.3% increased Q2 2020 10 quarters
ADI Analog Devices 0.9% 1,422,672 198.2M USD +148.9% increased Q2 2020 10 quarters
GM General Motors 0.6% 4,130,470 132.5M USD +72.6% increased Q2 2020 10 quarters
Uniqure NV 0.4% 4,259,886 79.9M USD +11.5% increased Q2 2020 10 quarters
CB Chubb Limited 0.3% 423,191 77.0M USD +99.0% increased Q2 2020 10 quarters
Radnet Inc 0.2% 1,811,974 36.9M USD +22.0% increased Q2 2020 10 quarters
Elastic N V 0.1% 444,538 31.9M USD +16.4% increased Q2 2020 10 quarters
Allete Inc < 0.1% 343,100 17.2M USD +96.2% increased Q2 2020 10 quarters
WRB W. R. Berkley Corporation < 0.1% 157,450 10.2M USD +21.6% increased Q2 2020 10 quarters
Melco Resorts And Entmnt Ltd < 0.1% 1,530,198 10.1M USD +78.6% increased Q2 2020 10 quarters
Angi Inc < 0.1% 1,875,814 5.5M USD +10.3% increased Q2 2020 10 quarters
Ringcentral Inc < 0.1% 54,385 2.2M USD +1,130.2% increased Q2 2020 10 quarters
BIIB Biogen 2.0% 1,677,982 448.0M USD +268.1% increased Q3 2020 9 quarters
CSX CSX Corporation 0.6% 4,808,127 128.1M USD +201.4% increased Q3 2020 9 quarters
Arcutis Biotherapeutics Inc 0.3% 3,785,277 72.3M USD +90.5% increased Q3 2020 9 quarters
Antero Resources Corp 0.3% 2,323,286 70.9M USD +9.3% increased Q3 2020 9 quarters
Biomarin Pharmaceutical Inc 0.2% 595,400 50.5M USD +302.6% increased Q3 2020 9 quarters
CRL Charles River Laboratories 0.2% 211,900 41.7M USD +1,360.1% increased Q3 2020 9 quarters
Markel Corp 0.1% 24,969 27.1M USD +39.5% increased Q3 2020 9 quarters
Transalta Corp < 0.1% 1,810,372 16.0M USD +370.2% increased Q3 2020 9 quarters
Azure Pwr Global Ltd < 0.1% 239,253 1.3M USD +48.1% increased Q3 2020 9 quarters
Vnet Group Inc < 0.1% 54,900 302.0K USD +6,000.0% increased Q3 2020 9 quarters
Inspire Med Sys Inc 0.4% 488,672 86.7M USD +66.3% increased Q4 2020 8 quarters
Chinook Therapeutics Inc 0.2% 2,440,754 48.0M USD +0.9% increased Q4 2020 8 quarters
CCEP Coca-Cola Europacific Partners < 0.1% 491,103 20.9M USD +191.0% increased Q4 2020 8 quarters
Ultragenyx Pharmaceutical In < 0.1% 350,687 14.5M USD +28.2% increased Q4 2020 8 quarters
Pulmonx Corp < 0.1% 526,797 8.8M USD +33.8% increased Q4 2020 8 quarters
Alphatec HLDGS Inc < 0.1% 915,200 8.0M USD +28.7% increased Q4 2020 8 quarters
ANET Arista Networks 1.0% 1,977,909 223.3M USD +4.6% increased Q1 2021 7 quarters
APA APA Corporation 0.5% 3,102,505 106.1M USD +139.1% increased Q1 2021 7 quarters
MSI Motorola Solutions 0.4% 427,995 95.9M USD +181.9% increased Q1 2021 7 quarters
Sarepta Therapeutics Inc 0.4% 851,900 94.2M USD +100.2% increased Q1 2021 7 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 297 positions.

Plus 367 option positions, value of the underlying shares as reported 2.0B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 328.4M USD
  • SPDR S&P 500 ETF TR Call 103.3M USD
  • Invesco Db Multi-Sector Comm Call 90.1M USD
  • Gsk PLC Call 72.1M USD
  • Ishares TR Put 58.3M USD
  • Select Sector SPDR TR Call 53.3M USD
  • Medical Pptys Trust Inc Put 51.3M USD
  • Apple Inc. Put 39.0M USD
  • Microsoft Put 32.1M USD
  • Sanofi Call 28.5M USD
Plus 44 positions in convertible bonds and bonds worth 400.1M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Novavax Inc principal 38.9M USD 38.2M USD
  • Dish Network Corporation principal 37.0M USD 24.3M USD
  • Royal Caribbean Group principal 21.4M USD 20.2M USD
  • Spotify USA Inc principal 24.5M USD 19.4M USD
  • Ford Mtr Co Del principal 20.8M USD 19.1M USD
  • Avalara Inc principal 18.5M USD 17.9M USD
  • Docusign Inc principal 17.5M USD 16.4M USD
  • Ringcentral Inc principal 18.2M USD 15.3M USD
  • Wayfair Inc principal 18.1M USD 15.1M USD
  • Sarepta Therapeutics Inc principal 9.0M USD 15.0M USD

Breakdown by sector

  • Technology 12.2%
  • Consumer Discretionary 7.6%
  • Health Care 7.5%
  • Financials 6.1%
  • Industrials 4.0%
  • Communication Services 3.8%
  • Utilities 3.2%
  • Consumer Staples 2.5%
  • Energy 2.4%
  • Materials 1.8%
  • Real Estate 1.2%
  • not in our coverage 47.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close